Similar articles for PMID: 29695635

Year	Number of Results
2009	2
2010	4
2011	5
2012	5
2013	10
2014	11
2015	14
2016	18
2017	21
2018	16
2019	17
2020	28
2021	23
2022	15
2023	7
2024	0

1

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells.

Li G, Guo J, Shen BQ, Yadav DB, Sliwkowski MX, Crocker LM, Lacap JA, Phillips GDL. Li G, et al. Mol Cancer Ther. 2018 Jul;17(7):1441-1453. doi: 10.1158/1535-7163.MCT-17-0296. Epub 2018 Apr 25. Mol Cancer Ther. 2018. PMID: 29695635

2

Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation.

Yamashita-Kashima Y, Shu S, Osada M, Fujimura T, Yoshiura S, Harada N, Yoshimura Y. Yamashita-Kashima Y, et al. Cancer Chemother Pharmacol. 2020 Nov;86(5):641-654. doi: 10.1007/s00280-020-04138-5. Epub 2020 Sep 30. Cancer Chemother Pharmacol. 2020. PMID: 32997196 Free PMC article.

3

A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine.

Le Joncour V, Martins A, Puhka M, Isola J, Salmikangas M, Laakkonen P, Joensuu H, Barok M. Le Joncour V, et al. Mol Cancer Ther. 2019 Oct;18(10):1721-1730. doi: 10.1158/1535-7163.MCT-19-0207. Epub 2019 Jul 10. Mol Cancer Ther. 2019. PMID: 31292166

4

Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728.

Irie H, Kawabata R, Fujioka Y, Nakagawa F, Itadani H, Nagase H, Ito K, Uchida J, Ohkubo S, Matsuo K. Irie H, et al. Cancer Sci. 2020 Jun;111(6):2123-2131. doi: 10.1111/cas.14407. Epub 2020 Apr 30. Cancer Sci. 2020. PMID: 32248641 Free PMC article.

5

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer.

Sabbaghi M, Gil-Gómez G, Guardia C, Servitja S, Arpí O, García-Alonso S, Menendez S, Arumi-Uria M, Serrano L, Salido M, Muntasell A, Martínez-García M, Zazo S, Chamizo C, González-Alonso P, Madoz-Gúrpide J, Eroles P, Arribas J, Tusquets I, Lluch A, Pandiella A, Rojo F, Rovira A, Albanell J. Sabbaghi M, et al. Clin Cancer Res. 2017 Nov 15;23(22):7006-7019. doi: 10.1158/1078-0432.CCR-17-0696. Epub 2017 Aug 18. Clin Cancer Res. 2017. PMID: 28821558

6

Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.

Saatci Ö, Borgoni S, Akbulut Ö, Durmuş S, Raza U, Eyüpoğlu E, Alkan C, Akyol A, Kütük Ö, Wiemann S, Şahin Ö. Saatci Ö, et al. Oncogene. 2018 Apr;37(17):2251-2269. doi: 10.1038/s41388-017-0108-9. Epub 2018 Feb 2. Oncogene. 2018. PMID: 29391599

7

STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancer.

Wang L, Wang Q, Gao M, Fu L, Li Y, Quan H, Lou L. Wang L, et al. Cancer Sci. 2018 Oct;109(10):3305-3315. doi: 10.1111/cas.13761. Epub 2018 Aug 31. Cancer Sci. 2018. PMID: 30076657 Free PMC article.

8

Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

Perez EA, de Haas SL, Eiermann W, Barrios CH, Toi M, Im YH, Conte PF, Martin M, Pienkowski T, Pivot XB, Burris HA 3rd, Stanzel S, Patre M, Ellis PA. Perez EA, et al. BMC Cancer. 2019 May 30;19(1):517. doi: 10.1186/s12885-019-5687-0. BMC Cancer. 2019. PMID: 31146717 Free PMC article. Clinical Trial.

9

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers.

Baldassarre T, Truesdell P, Craig AW. Baldassarre T, et al. Breast Cancer Res. 2017 Oct 3;19(1):110. doi: 10.1186/s13058-017-0900-z. Breast Cancer Res. 2017. PMID: 28974266 Free PMC article.

10

HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer.

Sakai H, Tsurutani J, Iwasa T, Komoike Y, Sakai K, Nishio K, Nakagawa K. Sakai H, et al. Breast Cancer. 2018 Sep;25(5):605-613. doi: 10.1007/s12282-018-0861-9. Epub 2018 Apr 26. Breast Cancer. 2018. PMID: 29700710 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

167 results

Results by year